Organization Overview
Alternative names
arsenic trioxide (trisenox) (1 trial)
bacille calmette-guerin (2 trials)
etoposide (vepesid) (2 trials)
gemtuzumab ozogamicin (mylotarg) (2 trials)
Alzheimer Disease (Phase 2)
Ataxia (Phase 2)
Atherosclerosis (Phase 4)
Cerebellar Ataxia (Phase 2)
Colitis, Ulcerative (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Restenosis (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Dyslipidemias (Phase 3)
Friedreich Ataxia (Phase 2)
Hodgkin Disease (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 1)
Leukemia, Promyelocytic, Acute (Phase 3)
Melanoma (Phase 1)
Metabolic Syndrome (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 3)
Parkinson Disease (Phase 3)
Poisoning (Phase 2)
Proctitis (Phase 2)
Proctocolitis (Phase 2)
Syndrome (Phase 4)
Ulcer (Phase 2)
Urinary Bladder Neoplasms (Phase 3)